• Adopting a Rare Son with Paul Compton

  • Aug 7 2024
  • Durée : 34 min
  • Podcast

Adopting a Rare Son with Paul Compton

  • Résumé

  • Paul Compton and his wife Andrea chose to start a family through adoption. Unknown to anyone, one of their adopted boys, Taeson, was the inheritor of DRPLA, a progressive brain disorder caused by a mutation in the ATN1 gene. Determined to find a treatment and advocate for their son and others with the disease, the Comptons established CureDRPLA. In early 2024, Taeson received his initial treatment with an ASO discovered and developed by n-Lorem. Paul discusses his family’s journey and shares his observations of Taeson's progress since beginning treatment.

    In This Episode We Discuss:

    3:05 – Paul's origins in business and finance

    4:32 - Investment banking is different than traditional banking

    7:27 – Opposites attract – Meeting his wife, Andrea, and starting a family through adoption

    10:06 – Paul’s son, Tayson, has a progressive brain disorder known as DRPLA, which is caused by a mutation in the ATN1 gene; Discovering the idea of n-Lorem

    16:03 – Tayson’s journey to a diagnosis

    23:00 – The deterioration of his abilities over the years

    25:00 – The progress Paul has observed in his son since initial treatment

    Links:

    Take our survey and receive an n-Lorem Store coupon code

    Register for the 2024 Nano-rare Patient Colloquium / October 30-31, 2024

    Make Hope Possible with a donation

    Afficher plus Afficher moins
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

    Ce que les auditeurs disent de Adopting a Rare Son with Paul Compton

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.